XML 38 R28.htm IDEA: XBRL DOCUMENT v3.5.0.2

Net Loss Per Share (Tables)

6 Months Ended

Jun. 30, 2016

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following tables reconcile the components of the numerator and denominator included in the calculations of diluted loss per share:

	Three Months Ended June 30,
	2016				2015
Numerator
Net loss attributable to Inovio Pharmaceuticals, Inc.	$	(18,704,711	)		$	(6,248,250	)
Reflect adjustment for decrease in fair value of warrant liability	—				(22,727		)
Numerator for use in diluted loss per share	$	(18,704,711	)		$	(6,270,977	)
Denominator
Weighted average number of common shares outstanding	72,957,159				67,655,975
Effect of dilutive potential common shares	—				182,763
Denominator for use in diluted loss per share	72,957,159				67,838,738
Net loss per share, diluted	$	(0.26	)		$	(0.09	)

	Six Months Ended June 30,
	2016				2015
Numerator
Net loss attributable to Inovio Pharmaceuticals, Inc.	$	(26,747,531	)		$	(16,830,029	)
Reflect adjustment for decrease in fair value of warrant liability	—				(312,500		)
Numerator for use in diluted loss per share	$	(26,747,531	)		$	(17,142,529	)
Denominator
Weighted average number of common shares outstanding	72,591,986				64,198,528
Effect of dilutive potential common shares	—				177,995
Denominator for use in diluted loss per share	72,591,986				64,376,523
Net loss per share, diluted	$	(0.37	)		$	(0.27	)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table summarizes potential common shares that were excluded from the diluted net loss per share calculation because of their anti-dilutive effect for the three and six months ended June 30, 2016 and 2015:

Common Stock Equivalents	2016			2015
Options to purchase common stock	6,694,478			5,987,210
Warrants to purchase common stock	284,091			627,969
Restricted stock units	749,335			230,000
Convertible preferred stock	8,456			8,456
Total	7,736,360			6,853,635

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration